MARKET

GNTA

GNTA

Genenta Science Spa
NASDAQ
1.460
-0.040
-2.67%
After Hours: 1.450 -0.01 -0.68% 16:10 12/24 EST
OPEN
1.440
PREV CLOSE
1.500
HIGH
1.490
LOW
1.430
VOLUME
23.00K
TURNOVER
--
52 WEEK HIGH
10.00
52 WEEK LOW
1.280
MARKET CAP
27.95M
P/E (TTM)
-2.6378
1D
5D
1M
3M
1Y
5Y
1D
Maxim Group Sticks to Their Buy Rating for Genenta Science SpA Sponsored ADR (GNTA)
TipRanks · 1d ago
Weekly Report: what happened at GNTA last week (1215-1219)?
Weekly Report · 2d ago
Weekly Report: what happened at GNTA last week (1208-1212)?
Weekly Report · 12/15 10:43
Market Pulse: Tilray Leads After-Hours Rally As Biotech Peers Surge
NASDAQ · 12/15 02:51
Weekly Report: what happened at GNTA last week (1201-1205)?
Weekly Report · 12/08 10:41
Weekly Report: what happened at GNTA last week (1124-1128)?
Weekly Report · 12/01 10:36
Weekly Report: what happened at GNTA last week (1117-1121)?
Weekly Report · 11/24 10:41
Genenta Science provides update from TEM-GBM study
TipRanks · 11/24 10:10
More
About GNTA
Genenta Science SpA is an Italy-based company engaged in clinical-stage biotechnology research. The Company focuses on the development of lentivirus-based gene and cell therapies in cancer. It uses gene-based cytokine delivery to activate the immune system within the tumor providing the anti-tumor response. The Company not only operates locally but also is present in global markets, including the United States.

Webull offers Genenta Science SPA (ADR) stock information, including NASDAQ: GNTA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GNTA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading GNTA stock methods without spending real money on the virtual paper trading platform.